Tag: US Securities and Exchange Commission (SEC)
Bryn Pharma Raises Another $15 Million for Commercialization of Needle-Free Intranasal...
Company is developing UTULY for intranasal emergency epinephrine delivery.
Mylan to Pay $30 Million for Disclosure and Accounting Failure Relating...
Mylan agreed to pay $30 million to settle charges they overcharged Medicaid hundreds of millions of dollars for EpiPen.
Developer of Revolutionary "Powder" Epinephrine Auto-Injector Raises $12 Million
Windgap Medical is securing funding to continue development.
Government Shutdown Delays Review of AR101 Peanut Oral Immunotherapy Candidate
The FDA has shelved consideration of the drug until funding is restored.
Department of Justice Investigating Mylan Regarding Trade Compliance for Certain Products
Manufacturer of EpiPen complies with DOJ requests and warrant issued by a special prosecutor's office in Milan, Italy.
Food Allergen Detector Draws $20 Million in Venture Funding
The device joins others intended for use as portable "point of consumption" testers.
